Structural basis of end-stage failure in ischemic cardiomyopathy in humans

scientific article

Structural basis of end-stage failure in ischemic cardiomyopathy in humans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.89.1.151
P698PubMed publication ID8281642

P2093author name stringFeruglio GA
Rocco M
Beltrami CA
Anversa P
Sonnenblick EH
Olivetti G
Puricelli C
Cigola E
Quaini F
Finato N
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectischemic cardiomyopathyQ12075432
P304page(s)151-163
P577publication date1994-01-01
P1433published inCirculationQ578091
P1476titleStructural basis of end-stage failure in ischemic cardiomyopathy in humans
P478volume89

Reverse relations

cites work (P2860)
Q51725730A Multidisciplinary Assessment of Remote Myocardial Fibrosis After Reperfused Myocardial Infarction in Swine and Patients.
Q51817202A mathematical model to evaluate control strategies for mechanical circulatory support.
Q77933851A novel biochemical approach to congestive heart failure: cardiac troponin T
Q73597772Abnormalities of cardiocytes in regions bordering fibrous scars of dogs with heart failure
Q64084663Acellular Extracellular Matrix Bioscaffolds for Cardiac Repair and Regeneration
Q35047817Activation of endoplasmic reticulum stress response during the development of ischemic heart disease
Q34459268Adaptive registration of varying contrast-weighted images for improved tissue characterization (ARCTIC): application to T1 mapping
Q37190311Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts
Q38733754Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease.
Q36252910Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance
Q64264854Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
Q38596695Aging Effects on Cardiac Progenitor Cell Physiology
Q35155965Aging and Cardiac Fibrosis.
Q44142573An ovine model of postinfarction dilated cardiomyopathy
Q34490923Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes
Q30846548Apoptosis in dilated cardiomyopathy
Q73352327Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device
Q93089068Application of Bioengineered Materials in the Surgical Management of Heart Failure
Q52656822Assessment of Remote Myocardium Heterogeneity in Patients with Ventricular Tachycardia Using Texture Analysis of Late Iodine Enhancement (LIE) Cardiac Computed Tomography (cCT) Images.
Q36298226Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality
Q79337302Atrophic degeneration and loss of myocytes of residual left ventricular myocardium after Dor operation for ischemic cardiomyopathy associated with left ventricular remodeling
Q43509334Attenuation of isoproterenol-mediated myocardial injury in rat by an inhibitor of polyamine synthesis
Q38447384Automated scar quantification by CMR: a step in the right direction.
Q90223979Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
Q73925072Backscattered electron imaging: A new method for the study of cardiomyocyte architecture using scanning electron microscopy
Q35571962Biomaterial strategies for alleviation of myocardial infarction
Q90593191CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema
Q53823555Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Q38984959Can Adiponectin Help us to Target Diastolic Dysfunction?
Q52936783Cardiac MRI Anatomy and Function as a Substrate for Arrhythmias.
Q34200316Cardiac Regeneration using Human Embryonic Stem Cells: Producing Cells for Future Therapy
Q24615347Cardiac applications for human pluripotent stem cells
Q41899486Cardiac remodelling
Q37294677Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration
Q36267790Cardiac stem cells and mechanisms of myocardial regeneration
Q37206379Cardiac stem cells and myocardial disease
Q83150650Cardiac tissue engineering
Q31148531Cardiomyocyte regeneration from circulating bone marrow cells in mice
Q46740748Carvedilol improves myocardial contractility compared with metoprolol in patients with chronic hibernating myocardium after revascularization
Q38072123Caspase-3 as a therapeutic target for heart failure.
Q36903477Caspases in myocardial infarction.
Q35138063Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited
Q77802850Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair?
Q34061092Cellular and molecular pathways to myocardial necrosis and replacement fibrosis
Q34432633Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation
Q37502208Chemokines and cardiac fibrosis.
Q44559048Chronic coronary artery stenosis induces impaired function of remote myocardium: MRI and spectroscopy study in rat.
Q35581752Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure
Q44485638Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium
Q33713690Clinical insights on the use of highly sensitive cardiac troponin assays
Q74180241Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling
Q36054295Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium
Q90627860Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction
Q36662036Concise review: stem cells, myocardial regeneration, and methodological artifacts
Q42425309Congestive heart failure: where homeostasis begets dyshomeostasis
Q34032407Connective tissue and the heart. Functional significance and regulatory mechanisms
Q35774278Contemporary perspective on endogenous myocardial regeneration
Q77298825Coronary artery constriction in rats: necrotic and apoptotic myocyte death
Q35005455Development of a xeno-free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood
Q73008868Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure
Q43544082Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin
Q36114162Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones
Q52566595Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart.
Q30375302EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.
Q55638585EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.
Q45939560EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.
Q54638672Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.
Q51847409Early maternal separation has mild effects on cardiac autonomic balance and heart structure in adult male rats.
Q40991721Effect of nitrates on myocardial remodeling after acute myocardial infarction
Q33223037Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction
Q46916947Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts
Q34578568Electrical and structural remodeling of the failing ventricle
Q37394544Evaluating the hemodynamical response of a cardiovascular system under support of a continuous flow left ventricular assist device via numerical modeling and simulations
Q77947869Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats
Q81606863Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies
Q35955262Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology
Q92309133Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure
Q38057701Fibrosis and heart failure
Q35660795Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system
Q34869712G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts
Q52563144Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
Q34525560Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium
Q33738009Growth hormone therapy for heart failure: swimming against the stream
Q49917885Guidelines for Experimental Models of Myocardial Ischemia and Infarction
Q37994258HIF-prolyl hydroxylases and cardiovascular diseases
Q73853044Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy
Q47608058Histopathologic Assessment of Myocardial Regeneration
Q78594584Histopathologic time course of myocardial infarct in rabbit hearts
Q37878952Identification of a coronary stem cell in the human heart
Q44856581Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy
Q53980136Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats.
Q21284499Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
Q37293114Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathway
Q38631821Integrins and integrin-related proteins in cardiac fibrosis
Q35500640Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.
Q38161896Investigational drugs targeting cardiac fibrosis
Q73622517Is apoptosis present in progression to chronic hypertensive heart failure?
Q43917350Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium
Q40528523Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia
Q61455288Left Ventricular Remodelling in Post-myocardial Infarction Patients with Left Ventricular Ejection Fraction 40-50% vs 25-39%. Influence of Nisoldipine Treatment?: An Echocardiographic Substudy from the DEFIANT II Study
Q45764505Left ventricular morphology of the giraffe heart examined by stereological methods
Q44054779Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
Q33557290MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium
Q37090568Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Q26824231Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies
Q35102230Mapping genetic contributions to cardiac pathology induced by Beta-adrenergic stimulation in mice
Q34340393Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications
Q46639330Mechanism of sudden cardiac death in pigs with viable chronically dysfunctional myocardium and ischemic cardiomyopathy
Q93099741Mechanisms of cardiac collagen deposition in experimental models and human disease
Q36699897Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure
Q35490630Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide
Q37296154Metabolic modulation and cellular therapy of cardiac dysfunction and failure
Q36597950Mineralocorticoid receptor antagonism confers cardioprotection in heart failure
Q36477618Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease
Q37983499Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states
Q28389063Mitochondrial dysfunction in cardiac aging
Q42803419Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol
Q31002195Mobilized bone marrow cells repair the infarcted heart, improving function and survival
Q28116119Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction
Q30274835Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model
Q36836362Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
Q37371632Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.
Q26996570Myocardial Tissue Characterization: Histological and Pathophysiological Correlation
Q44008848Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.
Q37623441Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission.
Q34686973Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus
Q38632039Myocardial infarction: stem cell transplantation for cardiac regeneration.
Q54943621Myocardial native T1 and extracellular volume with healthy ageing and gender.
Q37926160Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease
Q33853869Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure
Q37641749Myocardial remodeling after infarction: the role of myofibroblasts
Q73711201Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent
Q36221185Myocyte proliferation in end-stage cardiac failure in humans
Q37357150Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation
Q38294134Myofibroblast secretome and its auto-/paracrine signaling
Q38064729Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Q41391367Myofibroblasts and local angiotensin II in rat cardiac tissue repair
Q37972978Myofibroblasts in the infarct area: concepts and challenges
Q50916534Native T1 value in the remote myocardium is independently associated with left ventricular dysfunction in patients with prior myocardial infarction.
Q77111607Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling
Q34664054Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts
Q37373506Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
Q35146909Pathogenetic basis of myocardial dysfunction and amenability to reversal
Q41733651Pathological versus physiological left ventricular hypertrophy: a review
Q40581661Pathophysiologic aspects of end-stage heart failure
Q34972837Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling.
Q34239875Pathophysiology of chronic heart failure
Q54500659Patient profile modulates cardiac c-kit(+) progenitor cell availability and amplification potential.
Q34357219Pericytes at the intersection between tissue regeneration and pathology
Q80539477Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion
Q41715319Prevention of ventricular remodeling
Q40296183Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure
Q28084341Quality control systems in cardiac aging
Q37264534Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure
Q57621915Recent Developments in Imaging of Myocardial Angiotensin Receptors
Q48831553Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Q37638903Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy
Q39221569Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease
Q91581869Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins
Q73476733Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium
Q37116380Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction
Q37104058Repairing damaged myocardium: evaluating cells used for cardiac regeneration
Q36176076Reverse remodeling and recovery from cachexia in rats with aldosteronism
Q36203123Role of apoptosis in ventricular remodeling
Q49526018Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease
Q35820877Sarcomere alignment is regulated by myocyte shape
Q46745968Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Q36597800Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease
Q37005901Sex-related differences in intrinsic myocardial properties influence cardiac function in middle-aged rats during infarction-induced left ventricular remodeling
Q41906276Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery
Q37544884Stem cell therapy for cardiac repair: benefits and barriers
Q38046544Stem cell transplantation as a therapy for cardiac fibrosis.
Q37261623Stem cells for heart cell therapies
Q37708148Stem cells for heart failure in the aging heart
Q37977013Structural remodeling and mechanical function in heart failure
Q37717191Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification
Q42790907T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure.
Q36417705T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.
Q38190880T1 mapping in ischaemic heart disease
Q37352324TRPM7 is down-regulated in both left atria and left ventricle of ischaemic cardiomyopathy patients and highly related to changes in ventricular function.
Q34873016Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.
Q36642702Targeting angiogenesis versus myogenesis with cardiac cell therapy
Q37924999Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.
Q34892110Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure
Q46825442Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation
Q43096198Technology platform development for targeted plasma metabolites in human heart failure
Q60950146Temporal Frame of Immune Cell Infiltration during Heart Failure Establishment: Lessons from Animal Models
Q34086876Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload
Q33656014Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism
Q38177694The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction
Q64069385The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure
Q37579947The cardioprotective efficacy of TVP1022 against ischemia/reperfusion injury and cardiac remodeling in rats
Q42252887The human heart: a self-renewing organ
Q38033889The need for standardized protocols for future clinical trials of cell therapy
Q37161329The pathogenesis of cardiac fibrosis.
Q74660329The pathophysiology of advanced heart failure
Q30502828The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion.
Q42095427The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy
Q34061245The role of inflammatory and fibrogenic pathways in heart failure associated with aging.
Q41117393Three-dimension structure of ventricular myocardial fibers after myocardial infarction
Q55128147Three-dimensional Cardiomyocytes Structure Revealed By Diffusion Tensor Imaging and Its Validation Using a Tissue-Clearing Technique.
Q79899495Thymoglobulin administered early after heart transplantation reduces early myocardial hypertrophy assessed by morphometric studies
Q38322176Tissue engineering approaches to heart repair
Q28585906Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice
Q36915712Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.
Q46661981Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta
Q55322363Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy.
Q24625500Transient receptor potential (TRP) channels and cardiac fibrosis
Q40026105Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism
Q37298352Wall thickness of coronary vessels varies transmurally in the LV but not the RV: implications for local stress distribution
Q47097309Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine
Q73074717[Plasticity of the myocardium in pediatric cardiology]
Q34603394β-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling

Search more.